COVID-19 is an emerging, rapidly evolving situation.

What people with cancer should know: https://www.cancer.gov/coronavirus

Guidance for cancer researchers: https://www.cancer.gov/coronavirus-researchers

Get the latest public health information from CDC: https://www.coronavirus.gov

Get the latest research information from NIH: https://www.nih.gov/coronavirus

Dexamethasone in Reducing Everolimus-Induced Oral Stomatitis in Patients With Cancer

This phase III trial studies how well dexamethasone works in reducing everolimus-induced oral stomatitis in patients with cancer. Dexamethasone may help to reduce the everolimus-induced oral stomatitis so as to improve quality of life in cancer patients.

Research Base: Alliance for Clinical Trials in Oncology
NCT ID: NCT03839940
NCI Protocol Number: A221701
Status: Recruiting

For more information see ClinicalTrials.gov

Interventions

Condition

Malignant Neoplasm

Trial Type

Supportive Care/Symptom Management/PROs

See a list of participating sites on ClinicalTrials.gov


˄
BACK TO
TOP